Oncolytic Virus Therapies Market Size, Share & Trends Analysis Report By Commercialized Therapies (Imlygic, Oncorine, RIGVIR), By Pipeline Therapies (Phase I, Phase II, Phase III, Phase IV), By Type of Virus (Genetically Engineered Oncolytic Virus, Reovirus (Respiratory Enteric Orphan Virus)), By Application (Solid Tumor, Hematological Malignancies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034
Last Updated: June 03, 2026 |
Author: Debashree B |
Format: |
Report Code: SRHI3581DR |
Pages: 110